Latest Roche News and Updates : Roche updates, Roche News , Roche around the world

Nishadil

Washington | 25°C (scattered clouds)

Roche's Remarkable Rally: Diving into H1 2026 Performance and the Market's Surprising Enthusiasm

Top story

Roche's Remarkable Rally: Diving into H1 2026 Performance and the Market's Surprising Enthusiasm

In focus

Latest feed

Investor Optimism Fuels Roche's Ascent Amidst Nuanced H1 2026 Report

A New Dawn: Roche's Landmark Drug Redefines Hope for KRAS-Driven Lung Cancer Patients

A Renewed Sense of Hope: Roche's Ocrevus Continues to Impress in MS Care

Roche's Enduring Appeal: Navigating Growth Amidst Valuation Concerns

Latest headlines

A Quiet Revolution? Roche's New MS Drug Offers a Glimmer of Genuine Hope

A Quiet Revolution? Roche's New MS Drug Offers a Glimmer of Genuine Hope

A Landmark Clash: India's Supreme Court Navigates Life-Saving SMA Drugs, Patents, and Public Access

A Landmark Clash: India's Supreme Court Navigates Life-Saving SMA Drugs, Patents, and Public Access

A New Dawn for Breast Cancer Treatment: Roche's Gedatolisib and Giredestrant Combination Shows Promise

A New Dawn for Breast Cancer Treatment: Roche's Gedatolisib and Giredestrant Combination Shows Promise

Roche's Bold Leap: Pioneering Direct Patient Engagement for Enhanced Care

Roche's Bold Leap: Pioneering Direct Patient Engagement for Enhanced Care

A New Era for Alzheimer's Diagnosis: FDA Approves First Blood Test

A New Era for Alzheimer's Diagnosis: FDA Approves First Blood Test

A New Dawn for Diagnostics: FDA Approves First Blood Test for Alzheimer's Disease

A New Dawn for Diagnostics: FDA Approves First Blood Test for Alzheimer's Disease

A New Dawn for Alzheimer's Diagnosis: FDA Approves Roche and Eli Lilly's Groundbreaking Blood Test

A New Dawn for Alzheimer's Diagnosis: FDA Approves Roche and Eli Lilly's Groundbreaking Blood Test

Amneal Pharmaceuticals Eyes Major Market Entry with Xolair Biosimilar, Pledging Affordable Relief

Amneal Pharmaceuticals Eyes Major Market Entry with Xolair Biosimilar, Pledging Affordable Relief

A New Dawn: Scientists Achieve Landmark Breakthrough in Treating Huntington's Disease

A New Dawn: Scientists Achieve Landmark Breakthrough in Treating Huntington's Disease

A New Dawn: UK Gene Therapy Trial Offers Unprecedented Hope for Huntington's Disease

A New Dawn: UK Gene Therapy Trial Offers Unprecedented Hope for Huntington's Disease

Market Movers: Unpacking the Week's Most Impactful Corporate Deals and Strategic Shifts

Market Movers: Unpacking the Week's Most Impactful Corporate Deals and Strategic Shifts

Roche's Strategic Investment Ignites Excitement in the MASH Drug Development Landscape

Roche's Strategic Investment Ignites Excitement in the MASH Drug Development Landscape

Global Pharma Giants Set Sights on China: J&J and Roche Reportedly Eyeing Billion-Dollar Cancer Drug Deal with Henlius Biotech

Global Pharma Giants Set Sights on China: J&J and Roche Reportedly Eyeing Billion-Dollar Cancer Drug Deal with Henlius Biotech

Load more